Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward A Stadtmauer

Showing results (11-20 of 192) with videos related to

Pageof 20
Sort By:
Cancer Biology & Therapy|November 13, 2004
NF-kappaB, IL-6 and myeloma cell growth: making the connectionMark Y Chiang, Edward A Stadtmauer
Blood Cancer Discovery|September 28, 2023
Understanding Infection Risk with Anti-BCMA Bispecific AntibodiesAlfred L Garfall, Edward A Stadtmauer
Drugs & Aging|August 17, 2002
High-dose chemotherapy and stem cell support for breast cancer: where are we now?Renee M Gerrero, Steven Stein, Edward A Stadtmauer
The Annals of Pharmacotherapy|December 31, 2002
Concurrent administration of interferon alfa-2b and beta-1aTawee Tanvetyanon, Edward A Stadtmauer, Lawrence A Kerson
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|February 13, 2007
Medical management update: multiple myelomaEric T Stoopler, Dan T Vogl, Edward A Stadtmauer
The New England Journal of Medicine|January 14, 2016
Chimeric Antigen Receptor T Cells in MyelomaAlfred L Garfall, Edward A Stadtmauer, Carl H June
Leukemia|March 30, 2022
CAR T cell therapy for multiple myeloma: What have we learned?Sandra Susanibar Adaniya, Edward A Stadtmauer, Adam D Cohen
Cancer Journal (Sudbury, Mass.)|February 4, 2016
The Promise of Chimeric Antigen Receptor Engineered T Cells in the Treatment of Hematologic MalignanciesSarah J Nagle, Alfred L Garfall, Edward A Stadtmauer
Transfusion|February 1, 2013
The evolving role of plerixafor in hematopoietic progenitor cell mobilizationYvette C Tanhehco, Dan T Vogl, Edward A Stadtmauer, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Hematologic Malignancies: Plasma Cell DisordersMadhav V Dhodapkar, Ivan Borrello, Adam D Cohen, et al.
Pageof 20

Showing results (11-20 of 192) with videos related to

Sort By:
Pageof 20
Cancer Biology & Therapy|November 13, 2004
NF-kappaB, IL-6 and myeloma cell growth: making the connectionMark Y Chiang, Edward A Stadtmauer
Blood Cancer Discovery|September 28, 2023
Understanding Infection Risk with Anti-BCMA Bispecific AntibodiesAlfred L Garfall, Edward A Stadtmauer
Drugs & Aging|August 17, 2002
High-dose chemotherapy and stem cell support for breast cancer: where are we now?Renee M Gerrero, Steven Stein, Edward A Stadtmauer
The Annals of Pharmacotherapy|December 31, 2002
Concurrent administration of interferon alfa-2b and beta-1aTawee Tanvetyanon, Edward A Stadtmauer, Lawrence A Kerson
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|February 13, 2007
Medical management update: multiple myelomaEric T Stoopler, Dan T Vogl, Edward A Stadtmauer
The New England Journal of Medicine|January 14, 2016
Chimeric Antigen Receptor T Cells in MyelomaAlfred L Garfall, Edward A Stadtmauer, Carl H June
Leukemia|March 30, 2022
CAR T cell therapy for multiple myeloma: What have we learned?Sandra Susanibar Adaniya, Edward A Stadtmauer, Adam D Cohen
Cancer Journal (Sudbury, Mass.)|February 4, 2016
The Promise of Chimeric Antigen Receptor Engineered T Cells in the Treatment of Hematologic MalignanciesSarah J Nagle, Alfred L Garfall, Edward A Stadtmauer
Transfusion|February 1, 2013
The evolving role of plerixafor in hematopoietic progenitor cell mobilizationYvette C Tanhehco, Dan T Vogl, Edward A Stadtmauer, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Hematologic Malignancies: Plasma Cell DisordersMadhav V Dhodapkar, Ivan Borrello, Adam D Cohen, et al.
Pageof 20